# Targeted Radiotherapy for Recurrent Prostate Cancer

> **NCT05067660** · NA · UNKNOWN · sponsor: **Tampere University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Prostate Cancer Recurrence After Radical Prostatectomy

## Interventions

- **RADIATION:** Stereotactic ablative radiotherapy
- **RADIATION:** Current standard template-based salvage therapy

## Key facts

- **NCT ID:** NCT05067660
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05067660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05067660, "Targeted Radiotherapy for Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05067660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*